Rotterdam, Netherlands

Francesco Cerisoli

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesco Cerisoli: Innovator in Cancer Treatment

Introduction

Francesco Cerisoli is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of cancer treatment, particularly in the area of head and neck cancer. His innovative work has the potential to impact the lives of many patients suffering from this condition.

Latest Patents

Cerisoli holds a patent for a groundbreaking invention titled "MiRNA for treating head and neck cancer." This patent relates to the diagnostic and therapeutic uses of specific miRNA molecules, including miRNA-323, miRNA-342, miRNA-326, miRNA-371, miRNA-3157, and miRNA-345. These molecules are utilized in addressing diseases and conditions associated with squamous cell carcinoma, such as head and neck cancer or preneoplastic mucosal changes. He has 1 patent to his name.

Career Highlights

Throughout his career, Cerisoli has worked with various organizations that focus on scientific research and patient care. Notable companies he has been associated with include Interna Technologies B.V. and Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg. His work in these institutions has contributed to advancements in medical research and technology.

Collaborations

Cerisoli has collaborated with esteemed colleagues in his field, including Rudolf Henrikus Brakenhoff and Marlon Van Der Plas. These partnerships have fostered innovation and have been instrumental in the development of his research.

Conclusion

Francesco Cerisoli is a dedicated inventor whose work in miRNA technology holds promise for improving cancer treatment. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…